Skip to main content

Table 3 Clinical information received by the patients

From: Clinical management, expectations, and satisfaction of patients with moderate to severe allergic rhinoconjunctivitis treated with SQ-standardized grass-allergen tablet under routine clinical practice conditions in Spain

 

n

%

Did you receive information about your disease before starting the treatment with the allergen immunotherapy tablet? (n = 128)

Yes, in detail

114

89.1

Yes, a little

14

10.9

Did you receive information about the different treatments for your disease? (n = 129)

Yes, in detail

102

79.1

Yes, a little

25

19.4

I received no information

2

1.6

Did you receive information about the characteristics of the allergen immunotherapy tablet? (n = 128)

Yes, in detail

107

83.6

Yes, a little

20

15.6

I received no information

1

0.8

Did you receive written information about your disease or its treatment? (n = 128)

Yes

58

45.3

No

70

54.7